Bebtelovimab
RxNorm 2592360
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2592360 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: bebtelovimab.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
IN
Ingredient (IN):
Bebtelovimab
(Atom ID: 12728325)
PT
Designated preferred name (PT):
Bebtelovimab
(Atom ID: 12754959)
FN
Full form of descriptor (FN):
Bebtelovimab (substance)
(Atom ID: 12754960)
PT
Designated preferred name (PT):
Bebtelovimab-containing product
(Atom ID: 12754964)
FN
Full form of descriptor (FN):
Product containing bebtelovimab (medicinal product)
(Atom ID: 12756579)
Patient Education
Bebtelovimab Injection
Bebtelovimab injection is used to treat COVID-19 infection in certain non-hospitalized adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) and who have mild to moderate COVID-19 symptoms. It is used in people who have certain medical conditions that make them at higher risk for developing severe COVID-19 symptoms, including the need to be hospitalized from COVID-19 infection or death. Bebtelovimab is in a class called monoclonal antibodies. It works by blocking the action of a certain natural substance in the body in order to stop the spread of the virus.
[Learn More]
* Please review the disclaimer below.